Clinical observation of blue laser in the treatment of benign prostatic hyperplasia
10.3969/j.issn.1009-8291.2023.01.007
- VernacularTitle:450 nm蓝激光半导体治疗机侧输光治疗前列腺增生的临床疗效观察
- Author:
Xiaohang HAO
1
;
Teng LI
1
;
Fanzhuo TU
1
;
Zunjie HU
1
;
Yan HU
1
;
Yongwei ZHAO
1
Author Information
1. Urinary Nephropathy Laser Treatment Center, Yingsheng Branch of Taian Central Hospital, Taian 271000, China
- Publication Type:Journal Article
- Keywords:
benign prostatic hyperplasia;
blue laser;
green laser;
day surgery
- From:
Journal of Modern Urology
2023;28(1):29-31
- CountryChina
- Language:Chinese
-
Abstract:
【Objective】 To evaluate the clinical efficacy of 200 W blue laser vaporization of prostate and the possibility of developing such surgery into day surgery. 【Methods】 The clinical data of 30 patients treated during Aug. and Sep.2022 were retrospectively reviewed. The residual urine volume, urine flow rate, International Prostate Symptom Score (IPSS) and Quality of Life Scale(QoL) score before and after surgery were compared. The operation time and postoperative routine urinary red blood cell count were recorded. 【Results】 All surgeries were successful and the catheter was moved 1 day after surgery. The operation time was (12.2±5.1) min, postoperative bladder irrigation time (20.0±4.2) h, and urinary red blood cell count (806.2±16.3)/μL. Recatheter was needed in 1 patient. The urinary flow rate before surgery, immediately and 1-month after surgery were (10.6±3.5) mL/s, (24.2±5.6) mL/s, and (27.2±3.1) mL/s, respectively. The residual urine was (57.3±3.2) mL before surgery and (5.6±3.1) mL 1-month after surgery. The average preoperative IPSS and QoL scores were (25.1±1.6) and (5.4±0.7), and were (9.5±1.4) and (2.9±0.6), respectively, 3-months after surgery. 【Conclusion】 Transurethral 200 W blue laser vaporization of the prostate is a practical and feasible surgical technique for the treatment of benign prostatic hyperplasia. It is effective, rapid and safe, and can greatly shorten the length of hospital stay and improve perioperative safety. With the improvement of clinical application technology, it can be a choice of prostatic day surgery.
